Successful treatment of protein-losing enteropathy induced by intestinal lymphangiectasia in a liver cirrhosis patient with octreotide: A case report

Journal of Korean Medical Science

Volumn 19, Issue 3, 2004, Pages 466-469

  Lee, Hang Lak ^a   Han, Dong Soo ^a   Kim, Jin Bae ^a   Jeon, Yong Chul ^a   Sohn, Joo Hyun ^a   Hahm, Joon Soo ^a  

^a Hanyang University Guri Hospital   (South Korea)

Author keywords

Intestinal; Lymphagiectasis; Octreotide; Protein Losing Enteropathies

Indexed keywords

ALBUMIN TC 99M; OCTREOTIDE; PROTEIN; SERUM ALBUMIN;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COLONOSCOPY; DIAGNOSTIC PROCEDURE; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; DRUG COST; DRUG EFFECT; DUODENOSCOPY; EDEMA; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE LYMPHANGIECTASIA; LABORATORY TEST; LIVER CIRRHOSIS; MALE; PHYSICAL EXAMINATION; PROTEIN LOSING GASTROENTEROPATHY; RADIOGRAPHY; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 3042795201     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2004.19.3.466     Document Type: Article

References (15)

1. Sleisenger MH, Fordtran JS. Gastrointestinal disease: pathophysiology, diagnosis, management. 6th ed. Philadelphia: WB Saunders, 1998.
2. Kuroiwa G, Takayama T, Sato Y, Takahashi Y, Fujita T, Nobuoka A, Kukitsu T, Kato J, Sakamaki S, Niitsu Y. Primary intestinal lymphangiectasia successfully treated with octreotide. J Gastroenterol 2001; 36: 129-32.
3. Lee SH, Chang YW, Bak SK, Han JY, Kim JH, Jung YH, Lee BW, Han YS, Dong SH, Kim HJ, Kim BH, Lee JI, Chang R. A case of duodenal lymphangiectasia. Korean J Gastroenterol 2003; 41: 59-63.
4. Park GS, Kwak JY, Kim JS, Kwon TC, Jo YJ. A case of primary Intestinal lymphangiectasia. Korean J Gastrointest Endosc 1999; 19: 634-42.
5. Bac DJ, Van Hagen PM, Postema PT, ten Bokum AM, Zondervan PE, van Blankenstein M. Octreotide for protein-losing enteropathy with intestinal lymphangiectasia. Lancet 1995; 345: 1639.
6. Salvia G, Cascioli CF, Ciccimarra F, Terrin G, Cucchiara S. A case of protein-losing enteropathy caused by intestinal lymphangiectasia in a preterm infant. Pediatrics 2001; 107: 416-7.
7. Ballinger AB, Farthing MJ. Octreotide in the treatment of intestinal lymphangiectasia. Eur J Gastroenterol Hepatol 1998; 10: 699-702.
8. Patel AS, DeRidder PH. Endoscopic appearance and significance of functional lymphangiectasia of the duodenal mucosa. Gastrointest Endosc 1990; 36: 376-8.
9. Mine K, Matsubayashi S, Nakai Y, Nakagawa T. Intestinal lymphangiectasia markedly improved with antiplasmin therapy. Gastroenterology 1989; 96: 1596-9.
10. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996; 334: 246-54.
11. Heresbach D, Raoul JL, Genetet N, Noret P, Siproudhis L, Ramee MP, Bretagne JF, Gosselin M. Immunological study in primary intestinal lymphangiectasia. Digestion 1994; 55: 59-64.
12. Dousset B, Legmann P, Soubrane O, Chaussade S, Couturier D, Houssin D, Calmus Y. Protein-losing enteropathy secondary to hepatic venous outflow obstruction after liver transplantation. J Hepatol 1997; 27: 206-10.
13. Stanley AJ, Gilmour HM, Ghosh S, Ferguson A, McGilchrist AJ. Transjugular intrahepatic portosystemic shunt as a treatment for protein-losing enteropathy caused by portal hypertension. Gastroenterology 1996; 111: 1679-82.
14. Garcia-Pagan JC, Escorsell A, Moitinho E, Bosch J. Influence of pharmacological agents on portal hemodynamics: basis for its use in the treatment of portal hypertension. Seminar Liver Dis 1999; 19: 427-38.
15. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Seminar Liver Dis 1999; 19: 475-505.